Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Inventory (2022 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Inventory for 3 consecutive years, with $5.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Inventory fell 17.36% to $5.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.3 million, a 17.36% decrease, with the full-year FY2024 number at $5.3 million, down 17.36% from a year prior.
  • Inventory was $5.3 million for Q4 2024 at Whitehawk Therapeutics, down from $5.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $6.4 million in Q4 2023 to a low of $202000.0 in Q1 2022.
  • A 3-year average of $3.6 million and a median of $3.7 million in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: surged 1782.67% in 2023, then dropped 17.36% in 2024.
  • Whitehawk Therapeutics' Inventory stood at $1.9 million in 2022, then skyrocketed by 245.35% to $6.4 million in 2023, then dropped by 17.36% to $5.3 million in 2024.
  • Per Business Quant, the three most recent readings for WHWK's Inventory are $5.3 million (Q4 2024), $5.5 million (Q3 2024), and $6.1 million (Q2 2024).